biomarker

You have access
Measurement of PET Quantitative Bias In Vivo
Martin A. Lodge, Wojciech Lesniak, Michael A. Gorin, Kenneth J. Pienta, Steven P. Rowe and Martin G. Pomper

Journal of Nuclear Medicine May 10, 2021, 62 (5) 732-737; DOI: https://doi.org/10.2967/jnumed.120.251397
Open Access
Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): The NETPET score as a prognostic biomarker
David L Chan, Gary A Ulaner, David A. Pattison, David Wyld, Rahul Ladwa, Julian Kirchner, Bob T Li, W. Victoria Lai, Nick Pavlakis, PAUL J ROACH and Dale L. Bailey

Journal of Nuclear Medicine February 12, 2021, jnumed.120.257659; DOI: https://doi.org/10.2967/jnumed.120.257659
You have access
Data-Driven Prioritization and Review of Targets for Molecular-Based Theranostic Approaches in Pancreatic Cancer
Marjory Koller, Elmire Hartmans, Derk Jan A. de Groot, Xiao Juan Zhao, Gooitzen M. van Dam, Wouter B. Nagengast and Rudolf S.N. Fehrmann

Journal of Nuclear Medicine December 1, 2017, 58 (12) 1899-1903; DOI: https://doi.org/10.2967/jnumed.117.198440
You have access
⁸⁹Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma
Suzanne C. van Es, Adrienne H. Brouwers, Shekar V.K. Mahesh, Annemarie M. Leliveld-Kors, Igle J. de Jong, Marjolijn N. Lub-de Hooge, Elizabeth G.E. de Vries, Jourik A. Gietema and Sjoukje F. Oosting

Journal of Nuclear Medicine June 1, 2017, 58 (6) 905-910; DOI: https://doi.org/10.2967/jnumed.116.183475
You have access
Preclinical Evaluation of ¹⁸F-JNJ64349311, a Novel PET Tracer for Tau Imaging
Lieven Declercq, Frederik Rombouts, Michel Koole, Katleen Fierens, Jonas Mariën, Xavier Langlois, José Ignacio Andrés, Mark Schmidt, Gregor Macdonald, Diederik Moechars, Wim Vanduffel, Thomas Tousseyn, Rik Vandenberghe, Koen Van Laere, Alfons Verbruggen and Guy Bormans

Journal of Nuclear Medicine June 1, 2017, 58 (6) 975-981; DOI: https://doi.org/10.2967/jnumed.116.185199
You have access
Synthesis and Preclinical Evaluation of ¹¹C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain
Nabeel B. Nabulsi, Joël Mercier, Daniel Holden, Stephane Carré, Soheila Najafzadeh, Marie-Christine Vandergeten, Shu-fei Lin, Anand Deo, Nathalie Price, Martyn Wood, Teresa Lara-Jaime, Florian Montel, Marc Laruelle, Richard E. Carson, Jonas Hannestad and Yiyun Huang

Journal of Nuclear Medicine May 1, 2016, 57 (5) 777-784; DOI: https://doi.org/10.2967/jnumed.115.168179
You have access
TBCRC 008: Early Change in ¹⁸F-FDG Uptake on PET Predicts Response to Preoperative Systemic Therapy in Human Epidermal Growth Factor Receptor 2–Negative Primary Operable Breast Cancer
Roisin M. Connolly, Jeffrey P. Leal, Matthew P. Goetz, Zhe Zhang, Xian C. Zhou, Lisa K. Jacobs, Joyce Mhlanga, Joo H O, John Carpenter, Anna Maria Storniolo, Stanley Watkins, John H. Fetting, Robert S. Miller, Kostandinos Sideras, Stacie C. Jeter, Bridget Walsh, Penny Powers, Jane Zorzi, Judy C. Boughey, Nancy E. Davidson, Lisa A. Carey, Antonio C. Wolff, Nagi Khouri, Edward Gabrielson, Richard L. Wahl and Vered Stearns

Journal of Nuclear Medicine January 1, 2015, 56 (1) 31-37; DOI: https://doi.org/10.2967/jnumed.114.144741
You have access
Everolimus Reduces ⁸⁹Zr-Bevacizumab Tumor Uptake in Patients with Neuroendocrine Tumors
Sophie J. van Asselt, Sjoukje F. Oosting, Adrienne H. Brouwers, Alfons H.H. Bongaerts, Johan R. de Jong, Marjolijn N. Lub-de Hooge, Thijs H. Oude Munnink, Helle-Brit Fiebrich, Wim J. Sluiter, Thera P. Links, Annemiek M.E. Walenkamp and Elisabeth G.E. de Vries

Journal of Nuclear Medicine July 1, 2014, 55 (7) 1087-1092; DOI: https://doi.org/10.2967/jnumed.113.129056
You have access
Appropriate Use Criteria for Amyloid PET: A Report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association
Keith A. Johnson, Satoshi Minoshima, Nicolaas I. Bohnen, Kevin J. Donohoe, Norman L. Foster, Peter Herscovitch, Jason H. Karlawish, Christopher C. Rowe, Maria C. Carrillo, Dean M. Hartley, Saima Hedrick, Virginia Pappas and William H. Thies

Journal of Nuclear Medicine March 1, 2013, 54 (3) 476-490; DOI: https://doi.org/10.2967/jnumed.113.120618
You have access
Differences in the Biologic Activity of 2 Novel MEK Inhibitors Revealed by ¹⁸F-FDG PET: Analysis of Imaging Data from 2 Phase I Trials
Françoise Kraeber-Bodéré, Thomas Carlier, Valérie Meresse Naegelen, Eliezer Shochat, Jean Lumbroso, Carlos Trampal, James Nagarajah, Sue Chua, Florent Hugonnet, Marcel Stokkel, Fergus Gleeson and Jean Tessier

Journal of Nuclear Medicine December 1, 2012, 53 (12) 1836-1846; DOI: https://doi.org/10.2967/jnumed.112.109421

Main menu

User menu

Search

biomarker